The RNA revolution in medicine: from gene regulation to clinical therapeutics
Breakthrough discoveries in RNA biology have led to a paradigm shift in our understanding of RNA—from passive intermediates to active regulators of gene expression. Technological innovations and deeper insights into RNA regulation have transformed the field, positioning RNA as a powerful tool for th...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Animal Cells and Systems |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19768354.2025.2548253 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849224581234032640 |
|---|---|
| author | Jiwon Jeong Sunjoo Jeong |
| author_facet | Jiwon Jeong Sunjoo Jeong |
| author_sort | Jiwon Jeong |
| collection | DOAJ |
| description | Breakthrough discoveries in RNA biology have led to a paradigm shift in our understanding of RNA—from passive intermediates to active regulators of gene expression. Technological innovations and deeper insights into RNA regulation have transformed the field, positioning RNA as a powerful tool for therapeutic development. Recent advances in RNA technologies have revolutionized medicine by enabling the precise targeting of specific mRNAs to modulate aberrant transcripts, correct genetic defects, and reprogram cellular behavior. This review provides an overview of the coordinated regulation of mRNA processing and its application to RNA-based therapeutics, including antisense oligonucleotides (ASOs), splice-switching oligonucleotides (SSOs), small interfering RNAs (siRNAs), and Aptamers. We focus on clinically approved RNA therapeutics, emphasizing their biological mechanisms such as RNA stability and splicing regulation. The expanding repertoire of RNA technologies underscores the translational potential of RNA biology and its growing clinical impact. Future developments are expected to yield highly specific, modular, and programmable RNA medicines capable of treating a wide range of previously intractable diseases. |
| format | Article |
| id | doaj-art-b2e614a13539483fba780b06d9a4d63a |
| institution | Kabale University |
| issn | 1976-8354 2151-2485 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Animal Cells and Systems |
| spelling | doaj-art-b2e614a13539483fba780b06d9a4d63a2025-08-25T07:58:57ZengTaylor & Francis GroupAnimal Cells and Systems1976-83542151-24852025-12-0129152354310.1080/19768354.2025.2548253The RNA revolution in medicine: from gene regulation to clinical therapeuticsJiwon Jeong0Sunjoo Jeong1Laboratory of RNA Cell Biology, Department of Bioconvergence Engineering, Dankook University, Yongin, Republic of KoreaLaboratory of RNA Cell Biology, Department of Bioconvergence Engineering, Dankook University, Yongin, Republic of KoreaBreakthrough discoveries in RNA biology have led to a paradigm shift in our understanding of RNA—from passive intermediates to active regulators of gene expression. Technological innovations and deeper insights into RNA regulation have transformed the field, positioning RNA as a powerful tool for therapeutic development. Recent advances in RNA technologies have revolutionized medicine by enabling the precise targeting of specific mRNAs to modulate aberrant transcripts, correct genetic defects, and reprogram cellular behavior. This review provides an overview of the coordinated regulation of mRNA processing and its application to RNA-based therapeutics, including antisense oligonucleotides (ASOs), splice-switching oligonucleotides (SSOs), small interfering RNAs (siRNAs), and Aptamers. We focus on clinically approved RNA therapeutics, emphasizing their biological mechanisms such as RNA stability and splicing regulation. The expanding repertoire of RNA technologies underscores the translational potential of RNA biology and its growing clinical impact. Future developments are expected to yield highly specific, modular, and programmable RNA medicines capable of treating a wide range of previously intractable diseases.https://www.tandfonline.com/doi/10.1080/19768354.2025.2548253RNAantisense oligonucleotidessplicing switching oligonucleotidesRNA interferenceaptamers |
| spellingShingle | Jiwon Jeong Sunjoo Jeong The RNA revolution in medicine: from gene regulation to clinical therapeutics Animal Cells and Systems RNA antisense oligonucleotides splicing switching oligonucleotides RNA interference aptamers |
| title | The RNA revolution in medicine: from gene regulation to clinical therapeutics |
| title_full | The RNA revolution in medicine: from gene regulation to clinical therapeutics |
| title_fullStr | The RNA revolution in medicine: from gene regulation to clinical therapeutics |
| title_full_unstemmed | The RNA revolution in medicine: from gene regulation to clinical therapeutics |
| title_short | The RNA revolution in medicine: from gene regulation to clinical therapeutics |
| title_sort | rna revolution in medicine from gene regulation to clinical therapeutics |
| topic | RNA antisense oligonucleotides splicing switching oligonucleotides RNA interference aptamers |
| url | https://www.tandfonline.com/doi/10.1080/19768354.2025.2548253 |
| work_keys_str_mv | AT jiwonjeong thernarevolutioninmedicinefromgeneregulationtoclinicaltherapeutics AT sunjoojeong thernarevolutioninmedicinefromgeneregulationtoclinicaltherapeutics AT jiwonjeong rnarevolutioninmedicinefromgeneregulationtoclinicaltherapeutics AT sunjoojeong rnarevolutioninmedicinefromgeneregulationtoclinicaltherapeutics |